USA: A retrospective comparative effectiveness study among veterans with type 2 diabetes found that three GLP-1 receptor ...

GLP-1 receptor agonist therapy reduced surgical abscess repairs and hospitalizations among people with hidradenitis ...

"As of now, semaglutide is FDA-indicated for slowing chronic kidney disease progression, [but] our results suggest that ...

Researchers have identified that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are widely used to control type ...

The percentage of patients with a GLP-1 RA prescription before metabolic and bariatric surgery increased from 5.6% to 26.9% from 2020 to 2024.

Treatment with GLP-1 RAs was linked to decreased risks for all-cause mortality and MACE in patients with psoriasis when compared with other antidiabetic or obesity drugs.

Drugs targeting the glucagon-like peptide 1 receptor (GLP-1R) offer several positive effects for individuals with type 2 ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR. (HealthDay News) — For individuals with type 2 diabetes (T2D), ...

GLP-1 receptor agonists lead a new wave of therapeutic options that may benefit patients with osteoarthritis, according to ...

Observational data indicate that GLP-1 receptor agonists might be beneficial for kidney transplant recipients with diabetes. GLP-1 receptor agonists are associated with better kidney graft and ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...